1-800-567-8911 or
604-682-5050
(Telephone interpreting in over 150 languages available)
Plerixafor
Trade Name:
Mozobil
Manufacturer/Distributor:
Genzyme
www.genzyme.ca 1-877-220-8918
Classification:
Hematopoietic agent
ATC Class:
L03AX16 - plerixafor
Status:
active
Notice of Compliance (yyyy/mm/dd):
2011/12/08
Date Marketed in Canada (yyyy/mm/dd):
2012/01/26
Presentation:
Injection: 20 mg/mL. DIN: 02377225
Comments:
Plerixafor is indicated, in combination with granulocyte-colony stimulating factor (G-CSF), to mobilize hematopoietic stem cells to the peripheral blood for collection and subsequent autologous transplantation in patients with non-Hodgkin’s lymphoma and multiple myeloma.
Back to:
Drug Product Listings 
